Mobile app to support patients with multiple myeloma
Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multiple Myeloma
This study is testing a mobile app called THRIVE-M to see if it can help people with multiple myeloma feel better and cope with their condition compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06073353 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of a psychosocial mobile application called THRIVE-M in improving quality of life, reducing psychological distress, and alleviating fatigue in patients with multiple myeloma compared to standard care. The study addresses the psychological burden faced by these patients, who often experience significant morbidity due to their condition. By utilizing validated questionnaires, the trial will measure various patient-reported outcomes, including coping strategies and self-efficacy. The goal is to provide a tailored, innovative solution to enhance the psychosocial support available to this patient population.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with newly diagnosed, maintenance, or relapsed multiple myeloma.
Not a fit: Patients with acute or unstable psychiatric or cognitive conditions that hinder informed consent or compliance may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the psychological well-being and overall quality of life for patients living with multiple myeloma.
How similar studies have performed: While psychosocial interventions for cancer patients are common, this specific mobile application approach for multiple myeloma is novel and has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (aged 18 years or older) with one of the following diagnoses: 1. newly diagnosed multiple myeloma receiving first-line therapy, 2. multiple myeloma on maintenance therapy, or 3. relapsed multiple myeloma receiving 2nd or 3rd line therapy * Ability to comprehend, read, and respond to questions in English Exclusion Criteria: - Patients with acute or unstable psychiatric or cognitive conditions that the treating clinicians believe prohibit informed consent or compliance with study procedures
Where this trial is running
Boston, Massachusetts
- Massachusetts General Hospital — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Areej El-Jawahri, MD — Massachusetts General Hospital
- Study coordinator: Areej El-Jawahri, MD
- Email: ael-jawahri@mgb.org
- Phone: 617-724-4000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.